Mitochondria in chronic liver disease

Current Drug Targets

Volumn 12, Issue 6, 2011, Pages 879-893

  Grattagliano, Ignazio ^a   Russmann, Stefan ^b   Diogo, Cátia ^c   Bonfrate, Leonilde ^a   Oliveira, Paulo J ^c   Wang, David Q H ^d   Portincasa, Piero ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Cholestasis; Fatty liver; Hemochromatosis; Hepatitis C virus; Nitrosative stress; Nonalcoholic fatty liver disease; Oxidative stress; Primary biliary cirrhosis; Wilson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATE;

AEROBIC METABOLISM; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTASIS; CHRONIC LIVER DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEMOCHROMATOSIS; HEPATITIS A; LIVER CELL; LIVER CELL DAMAGE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION; WILSON DISEASE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL SURVIVAL; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; HEPATOCYTES; HUMANS; LIVER DISEASES; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION;

EID: 79955606583     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945011795528877     Document Type: Article

References (158)

1. Krahenbuhl S. Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention. Pharmacol Ther 1993; 60: 1-38.
2. Grattagliano I, Caraceni P, Portincasa P, et al. Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver. Cell Biol Toxicol 2003; 19: 355-66.
3. Grattagliano I, Caraceni P, Calamita G, et al. Severe liver steatosis correlates with nitrosative and oxidative stress in rats. Eur J Clin Invest 2008; 38: 523-30.
4. Kass GE. Mitochondrial involvement in drug-induced hepatic injury. Chem Biol Interact 2006; 163: 145-59.
5. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1366: 151-65.
6. Kass GE, Price SC. Role of mitochondria in drug-induced cholestatic injury. Clin Liver Dis 2008; 12: 27-51, vii.
7. Guerrieri F, Nicoletti C, Adorisio E, et al. Correlation between decreased expression of mitochondrial F0F1-ATP synthase and low regenerating capability of the liver after partial hepatectomy in hypothyroid rats. J Bioenerg Biomembr 2000; 32: 183-91.
8. Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8: 595-617, x.
9. Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology 2007; 45: 331-9.
10. Mantena SK, King AL, Andringa KK, Landar A, Darley-Usmar V, Bailey SM. Novel interactions of mitochondria and reactive oxygen/nitrogen species in alcohol mediated liver disease. World J Gastroenterol 2007; 13: 4967-73.
11. Kagan VE, Bayir HA, Belikova NA, et al. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med 2009; 46: 1439-53.
12. Feldmann G, Haouzi D, Moreau A, et al. Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology 2000; 31: 674-83.
13. Haouzi D, Lekehal M, Moreau A, et al. Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology 2000; 32: 303-11.
14. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134: 1641-54.
15. Pessayre D, Haouzi D, Fau D, Robin MA, Mansouri A, Berson A. Withdrawal of life support, altruistic suicide, fratricidal killing and euthanasia by lymphocytes: different forms of drug-induced hepatic apoptosis. J Hepatol 1999; 31: 760-70.
16. Slee EA, Adrain C, Martin SJ. Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001; 276: 7320-6.
17. Formigli L, Papucci L, Tani A, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000; 182: 41-9.
18. Papucci L, Formigli L, Schiavone N, et al. Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression. Cell Tissue Res 2004; 316: 197-209.
19. Tsukamoto H, Gaal K, French SW. Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology 1990; 12: 599-608.
20. Hall PD, Plummer JL, Ilsley AH, Cousins MJ. Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat. Hepatology 1991; 13: 815-9.
21. Lieber CS, Baraona E, Hernandez-Munoz R, et al. Impaired oxygen utilization. A new mechanism for the hepatotoxicity of ethanol in sub-human primates. J Clin Invest 1989; 83: 1682-90.
22. Chang ES. Ultrastructural morphogenesis of mitochondria in alcoholic liver. Acta Pathol Jpn 1987; 37: 213-24.
23. Yan M, Zhu P, Liu HM, Zhang HT, Liu L. Ethanol induced mitochondria injury and permeability transition pore opening: role of mitochondria in alcoholic liver disease. World J Gastroenterol 2007; 13: 2352-6.
24. Quintanilla ME, Tampier L. Sensitivity of liver mitochondrial functions to various levels of ethanol intake in the rat. Alcohol Clin Exp Res 1989; 13: 280-3.
25. Lauterburg BH, Bilzer M. Mechanisms of acetaldehyde hepatotoxicity. J Hepatol 1988; 7: 384-90.
26. Israel Y. Covalent binding of acetaldehyde to liver tubulin: a step in the right direction. Hepatology 1989; 9: 161-2.
27. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fernandez-Checa JC. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992; 16: 1423-7.
28. Lauterburg BH, Davies S, Mitchell JR. Ethanol suppresses hepatic glutathione synthesis in rats in vivo. J. Pharmacol. Exp. Ther. 1984; 230: 7-11.
29. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, Kaplowitz N. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 1991; 87: 397-405.
30. Spach PI, Bottenus RE, Cunningham CC. Control of adenine nucleotide metabolism in hepatic mitochondria from rats with ethanol-induced fatty liver. Biochem J 1982; 202: 445-52.
31. Thayer WS, Rubin E. Effects of chronic ethanol consumption on the respiratory chain of rat liver submitochondrial particles. Adv Exp Med Biol 1980; 132: 385-92.
32. Ribiere C, Hininger I, Saffar-Boccara C, Sabourault D, Nordmann R. Mitochondrial respiratory activity and superoxide radical generation in the liver, brain and heart after chronic ethanol intake. Biochem Pharmacol 1994; 47: 1827-33.
33. Montgomery RI, Coleman WB, Eble KS, Cunningham CC. Ethanol-elicited alterations in the oligomycin sensitivity and structural stability of the mitochondrial F0. F1 ATPase. J Biol Chem 1987; 262: 13285-9.
34. Coleman WB, Cunningham CC. Effects of chronic ethanol consumption on the synthesis of polypeptides encoded by the hepatic mitochondrial genome. Biochim Biophys Acta 1990; 1019: 142-50.
35. Young TA, Bailey SM, Van Horn CG, Cunningham CC. Chronic ethanol consumption decreases mitochondrial and glycolytic production of ATP in liver. Alcohol Alcohol 2006; 41: 254-60.
36. Venkatraman A, Shiva S, Wigley A, et al. The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice. Hepatology 2004; 40: 565-73.
37. Vendemiale G, Grattagliano I, Signorile A, Altomare E. Ethanolinduced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. J Hepatol 1998; 28: 46-53.
38. Wieland P, Lauterburg BH. Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun 1995; 213: 815-9.
39. Schilling RJ, Reitz RC. A mechanism for ethanol-induced damage to liver mitochondrial structure and function. Biochim Biophys Acta 1980; 603: 266-77.
40. Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16: 448-53.
41. Cahill A, Sykora P. Alcoholic liver disease and the mitochondrial ribosome: methods of analysis. Methods Mol Biol 2008; 447: 381-94.
42. Sykora P, Kharbanda KK, Crumm SE, Cahill A. S-adenosyl-Lmethionine co-administration prevents the ethanol-elicited dissociation of hepatic mitochondrial ribosomes in male rats. Alcohol Clin Exp Res 2009; 33: 1-9.
43. Bailey SM, Robinson G, Pinner A, et al. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver. Am J Physiol Gastrointest Liver Physiol 2006; 291: G857-G67.
44. Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367-73.
45. Berson A, De Beco V, Letteron P, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 764-74.
46. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 2005; 42: 928-40.
47. Calamita G, Portincasa P. Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets 2007; 11: 1231-49.
48. Fromenty B, Pessayre D. Inhibition of mitochondrial betaoxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101-54.
49. Yang S, Zhu H, Li Y, et al. Mitochondrial adaptations to obesityrelated oxidant stress. Arch Biochem Biophys 2000; 378: 259-68.
50. Merriman RB, Aouizerat BE, Bass NM. Genetic influences in nonalcoholic fatty liver disease. J Clin Gastroenterol 2006; 40 Suppl 1: S30-S33.
51. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
52. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999; 282: 1659-64.
53. Haque M, Sanyal AJ. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best. Pract. Res. Clin. Gastroenterol. 2002; 16: 709-31.
54. Perez-Carreras M, Del Hoyo P, Martin MA, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38: 999-1007.
55. Petrosillo G, Portincasa P, Grattagliano I, et al. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta 2007; 1767: 1260-7.
56. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 2002; 286: 135-41.
57. Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial glutathione: hepatocellular survival-death switch. J Gastroenterol Hepatol 2006; 21 Suppl 3: S3-S6.
58. Nikitovic D, Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996; 271: 19180-5.
59. Stoyanovsky DA, Tyurina YY, Tyurin VA, et al. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 2005; 127: 15815-23.
60. Arnelle DR, Stamler JS. NO+, NO, and NO-donation by Snitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 1995; 318: 279-85.
61. Grattagliano I, Portincasa P, Cocco T, et al. Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats. Exp Gerontol 2004; 39: 1323-32.
62. Garcia-Ruiz I, Rodriguez-Juan C, Diaz-Sanjuan T, et al. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 2006; 44: 581-91.
63. Wei Y, Clark SE, Thyfault JP, et al. Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. Am J Pathol 2009; 174: 1329-37.
64. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A. Mitochondrial glutathione: importance and transport. Semin Liver Dis 1998; 18: 389-401.
65. Grattagliano I, Vendemiale G, Lauterburg BH. Reperfusion injury of the liver: role of mitochondria and protection by glutathione ester. J Surg Res 1999; 86: 2-8.
66. Nardo B, Grattagliano I, Domenicali M, et al. Mitochondrial oxidative injury in rat fatty livers exposed to warm ischemiareperfusion. Transplant Proc 2000; 32: 51.
67. Minor T, Akbar S, Tolba R, Dombrowski F. Cold preservation of fatty liver grafts: prevention of functional and ultrastructural impairments by venous oxygen persufflation. J Hepatol 2000; 32: 105-11.
68. Miki C, Iriyama K, Mirza DF, et al. Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation. Dig Dis Sci 1998; 43: 74-9.
69. Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol 1996; 24: 114-21.
70. Hensley K, Kotake Y, Sang H, et al. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis 2000; 21: 983-9.
71. Barbaro G, Di Lorenzo G, Asti A, Ribersani M, Belloni G, Grisorio B, et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 1999; 94: 2198-205.
72. Kageyama F, Kobayashi Y, Kawasaki T, Toyokuni S, Uchida K, Nakamura H. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000; 95: 1041-50.
73. Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366-75.
74. Tsutsumi T, Matsuda M, Aizaki H, et al. Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein. Hepatology 2009; 50: 378-86.
75. Nomura-Takigawa Y, Nagano-Fujii M, Deng L, et al. Nonstructural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J Gen Virol 2006; 87: 1935-45.
76. Campbell RV, Yang Y, Wang T, et al. Chapter 20 Effects of hepatitis C core protein on mitochondrial electron transport and production of reactive oxygen species. Methods Enzymol 2009; 456: 363-80.
77. Piccoli C, Scrima R, Quarato G, et al. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 2007; 46: 58-65.
78. Li Y, Boehning DF, Qian T, Popov VL, Weinman SA. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J 2007; 21: 2474-85.
79. Williamson CD, Colberg-Poley AM. Access of viral proteins to mitochondria via mitochondria-associated membranes. Rev Med Virol 2009; 19: 147-64.
80. Barbaro G, Di Lorenzo G, Belloni G, Asti A, Pellicelli AM, Barbarini G. Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype. Dig Liver Dis 2001; 33: 81-3.
81. Matsumoto M, Hsieh TY, Zhu N, et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 1997; 71: 1301-9.
82. Zhu N, Khoshnan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998; 72: 3691-7.
83. Deng L, Adachi T, Kitayama K, et al. Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrionmediated, caspase 3-dependent pathway. J Virol 2008; 82: 10375-85.
84. Janssen MC, Swinkels DW. Hereditary haemochromatosis. Best Pract Res Clin Gastroenterol 2009; 23: 171-83.
85. Lee PL, Beutler E. Regulation of hepcidin and iron-overload disease. Annu Rev Pathol 2009; 4: 489-515.
86. Isom HC, McDevitt EI, Moon MS. Elevated hepatic iron: a confounding factor in chronic hepatitis C. Biochim Biophys Acta 2009; 1790: 650-62.
87. Levi S, Rovida E. The role of iron in mitochondrial function. Biochim Biophys Acta 2009; 1790: 629-36.
88. Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 2009; 1790: 589-99.
89. Corradini E, Ferrara F, Pietrangelo A. Iron and the liver. Pediatr. Endocrinol. Rev. 2004; 2 Suppl 2: 245-8.
90. Bacon BR, Park CH, Brittenham GM, O'Neill R, Tavill AS. Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload. Hepatology 1985; 5: 789-97.
91. Bacon BR, Britton RS, O'Neill R. Effects of vitamin E deficiency on hepatic mitochondrial lipid peroxidation and oxidative metabolism in rats with chronic dietary iron overload. Hepatology 1989; 9: 398-404.
92. Britton RS, O'Neill R, Bacon BR. Chronic dietary iron overload in rats results in impaired calcium sequestration by hepatic mitochondria and microsomes [corrected]. Gastroenterology 1991; 101: 806-11.
93. Britton RS, O'Neill R, Bacon BR. Hepatic mitochondrial malondialdehyde metabolism in rats with chronic iron overload. Hepatology 1990; 11: 93-7.
94. Jouihan HA, Cobine PA, Cooksey RC, et al. Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med 2008; 14: 98-108.
95. Pietrangelo A, Grandi R, Tripodi A, et al. Lipid composition and fluidity of liver mitochondria, microsomes and plasma membrane of rats with chronic dietary iron overload. Biochem Pharmacol 1990; 39: 123-8.
96. Bacon BR, O'Neill R, Park CH. Iron-induced peroxidative injury to isolated rat hepatic mitochondria. J Free Radic Biol Med 1986; 2: 339-47.
97. Zhang Y, Yang M, Park JH, et al. A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. Small 2009; 5: 1990-6.
98. Prohaska JR, Gybina AA. Intracellular copper transport in mammals. J Nutr 2004; 134: 1003-6.
99. Mehta R, Templeton DM, O'brien PJ. Mitochondrial involvement in genetically determined transition metal toxicity II. Copper toxicity. Chem Biol Interact 2006; 163: 77-85.
100. Stromeyer FW, Ishak KG. Histology of the liver in Wilson's disease: a study of 34 cases. Am J Clin Pathol 1980; 73: 12-24.
101. Sternlieb I. Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease. Hepatology 1992; 16: 728-32.
102. Mansouri A, Gaou I, Fromenty B, et al. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology 1997; 113: 599-605.
103. Sokol RJ, Devereaux M, Mierau GW, Hambidge KM, Shikes RH. Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Modification by vitamin E deficiency. Gastroenterology 1990; 99: 1061-71.
104. Gu M, Cooper JM, Butler P, et al. Oxidative-phosphorylation defects in liver of patients with Wilson's disease. Lancet 2000; 356: 469-74.
105. Belyaeva EA, Dymkowska D, Wieckowski MR, Wojtczak L. Mitochondria as an important target in heavy metal toxicity in rat hepatoma AS-30D cells. Toxicol Appl Pharmacol 2008; 231: 34-42.
106. Sheline CT, Choi DW. Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Ann Neurol 2004; 55: 645-53.
107. Roy DN, Mandal S, Sen G, Biswas T. Superoxide anion mediated mitochondrial dysfunction leads to hepatocyte apoptosis preferentially in the periportal region during copper toxicity in rats. Chem Biol Interact 2009; 182: 136-47.
108. Krumschnabel G, Manzl C, Berger C, Hofer B. Oxidative stress, mitochondrial permeability transition, and cell death in Cu-exposed trout hepatocytes. Toxicol Appl Pharmacol 2005; 209: 62-73.
109. Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607-12.
110. Feuchtinger M, Christ S, Preuss B, et al. Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis. Gut 2009; 58: 983-9.
111. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001; 33: 616-26.
112. Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol Sci 2000; 57: 177-85.
113. Rehman H, Ramshesh VK, Theruvath TP, et al. NIM811 (Nmethyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. J Pharmacol Exp Ther 2008; 327: 699-706.
114. Rolo AP, Oliveira PJ, Seica R, Santos MS, Moreno AJ, Palmeira CM. Improved efficiency of hepatic mitochondrial function in rats with cholestasis induced by an acute dose of alphanaphthylisothiocyanate. Toxicol Appl Pharmacol 2002; 182: 20-6.
115. Rolo AP, Oliveira PJ, Seica R, Santos MS, Moreno AJ, Palmeira CM. Disruption of mitochondrial calcium homeostasis after chronic alpha-naphthylisothiocyanate administration: relevance for cholestasis. J Investig Med 2002; 50: 193-200.
116. Krahenbuhl S, Krahenbuhl-Glauser S, Stucki J, Gehr P, Reichen J. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte. Hepatology 1992; 15: 1167-72.
117. Krahenbuhl S, Stucki J, Reichen J. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis. Hepatology 1992; 15: 1160-6.
118. Krahenbuhl S, Brass EP. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis. Hepatology 1991; 14: 927-34.
119. Sokol RJ, Devereaux M, Khandwala RA. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res 1991; 32: 1349-57.
120. Portincasa P, Grattagliano I, Testini M, et al. Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants. Free Radic Biol Med 2007; 42: 1381-91.
121. Tiao MM, Lin TK, Liou CW, et al. Early transcriptional deregulation of hepatic mitochondrial biogenesis and its consequent effects on murine cholestatic liver injury. Apoptosis 2009; 14: 890-9.
122. Carreras MC, Converso DP, Lorenti AS, et al. Mitochondrial nitric oxide synthase drives redox signals for proliferation and quiescence in rat liver development. Hepatology 2004; 40: 157-66.
123. Nisoli E, Clementi E, Paolucci C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003; 299: 896-9.
124. Chen T, Pearce LL, Peterson J, Stoyanovsky D, Billiar TR. Glutathione depletion renders rat hepatocytes sensitive to nitric oxide donor-mediated toxicity. Hepatology 2005; 42: 598-607.
125. Ottesen LH, Harry D, Frost M, et al. Increased formation of Snitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001; 31: 790-8.
126. Vendemiale G, Grattagliano I, Lupo L, Memeo V, Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol 2002; 37: 601-5.
127. Krahenbuhl S, Fischer S, Talos C, Reichen J. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. Hepatology 1994; 20: 1595-601.
128. Elpeleg O. Inherited mitochondrial DNA depletion. Pediatr Res 2003; 54: 153-9.
129. Alberio S, Mineri R, Tiranti V, Zeviani M. Depletion of mtDNA: syndromes and genes. Mitochondrion 2007; 7: 6-12.
130. Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006; 129: 1674-84.
131. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001; 29: 337-41.
132. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004; 55: 706-12.
133. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006; 38: 570-5.
134. Longley MJ, Graziewicz MA, Bienstock RJ, Copeland WC. Consequences of mutations in human DNA polymerase gamma. Gene 2005; 354: 125-31.
135. Bortot B, Barbi E, Biffi S, et al. Two novel POLG mutations causing hepatic mitochondrial DNA depletion with recurrent hypoketotic hypoglycaemia and fatal liver dysfunction. Dig Liver Dis 2009; 41: 494-9.
136. Kobayashi K, Sinasac DS, Iijima M, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 1999; 22: 159-63.
137. Palmieri L, Pardo B, Lasorsa FM, et al. Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 2001; 20: 5060-9.
138. Dierks T, Riemer E, Kramer R. Reaction mechanism of the reconstituted aspartate/glutamate carrier from bovine heart mitochondria. Biochim Biophys Acta 1988; 943: 231-44.
139. Iijima M, Jalil A, Begum L, et al. Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. Adv Enzyme Regul 2001; 41: 325-42.
140. Sinasac DS, Crackower MA, Lee JR, et al. Genomic structure of the adult-onset type II citrullinemia gene, SLC25A13, and cloning and expression of its mouse homologue. Genomics 1999; 62: 289-92.
141. Yasuda T, Yamaguchi N, Kobayashi K, et al. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 2000; 107: 537-45.
142. Sawada S, Kinjo T, Makishi S, et al. Downregulation of citrin, a mitochondrial AGC, is associated with apoptosis of hepatocytes. Biochem Biophys Res Commun 2007; 364: 937-44.
143. Iwata S, Ozawa K, Shimahara Y, et al. Diurnal fluctuations of arterial ketone body ratio in normal subjects and patients with liver dysfunction. Gastroenterology 1991; 100: 1371-8.
144. Yamaguchi T, Shimahara Y, Takada Y, et al. Evaluation of ketogenesis in seriously reduced hepatic mitochondrial redox state. An analysis of survivors and non-survivors in critically ill hepatectomized patients. Scand J Gastroenterol 1992; 27: 472-8.
145. Michaletz PA, Cap L, Alpert E, Lauterburg BH. Assessment of mitochondrial function in vivo with a breath test utilizing alphaketoisocaproic acid. Hepatology 1989; 10: 829-32.
146. Lauterburg BH, Liang D, Schwarzenbach FA, Breen KJ. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology 1993; 17: 418-22.
147. Lauterburg BH, Grattagliano I, Gmur R, Stalder M, Hildebrand P. Noninvasive assessment of the effect of xenobiotics on mitochondrial function in human beings: studies with acetylsalicylic acid and ethanol with the use of the carbon 13-labeled ketoisocaproate breath test. J. Lab Clin. Med. 1995; 125: 378-83.
148. Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006; 111: 135-43.
149. Bates CJ. Liberation of 14CO2 from [14C]adipic acid and [14C]octanoic acid by adult rats during riboflavin deficiency and its reversal. Br J Nutr 1990; 63: 553-62.
150. Miele L, Grieco A, Armuzzi A, et al. Hepatic mitochondrial betaoxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 2003; 98: 2335-6.
151. Gatley SJ, Sherratt HS. The synthesis of hippurate from benzoate and glycine by rat liver mitochondria. Submitochondrial localization and kinetics. Biochem J 1977; 166: 39-47.
152. Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Tracey BM, Millington DS. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child 1983; 58: 916-20.
153. Krahenbuhl L, Ledermann M, Lang C, Krahenbuhl S. Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced liver cirrhosis. J Hepatol 2000; 33: 216-23.
154. Bianchi G, Marchesini G, Vilstrup H, et al. Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method. Hepatology 1991; 13: 460-6.
155. Hamberg O, Nielsen K, Vilstrup H. Effects of an increase in protein intake on hepatic efficacy for urea synthesis in healthy subjects and in patients with cirrhosis. J Hepatol 1992; 14: 237-43.
156. Dufour JF, Stoupis C, Lazeyras F, Vock P, Terrier F, Reichen J. Alterations in hepatic fructose metabolism in cirrhotic patients demonstrated by dynamic 31phosphorus spectroscopy. Hepatology 1992; 15: 835-42.
157. Dagnelie PC, Menon DK, Cox IJ, et al. Effect of L-alanine infusion on 31P nuclear magnetic resonance spectra of normal human liver: towards biochemical pathology in vivo. Clin Sci (Lond) 1992; 83: 183-90.
158. Caldwell SH, Patrie JT, Brunt EM, et al. The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis. Hepatology 2007; 46: 1101-7.